SAN DIEGO, CA (January 8, 2025) – Element Biosciences, Inc., a developer of pioneering technologies to empower science, today announced that Element CEO and co-founder Molly He will be presenting a corporate update at the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place at 8:30am PT on Monday, January 13, 2025, at The Westin St. Francis Hotel.
%20Images/Element-JPM-2025-Final-1-copy.webp?width=300&height=169&name=Element-JPM-2025-Final-1-copy.webp)
About Element Biosciences, Inc.
Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multi-omics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries. To learn more about Element, please visit www.elementbiosciences.com and follow us on LinkedIn, X (Twitter), and Facebook.
Media Contact:
Element Biosciences
media@elembio.com